Literature DB >> 8344352

The expressed T cell receptor V gene repertoire of rheumatoid arthritis monozygotic twins: rapid analysis by anchored polymerase chain reaction and enzyme-linked immunosorbent assay.

H Kohsaka1, A Taniguchi, P P Chen, W E Ollier, D A Carson.   

Abstract

Because of heterogeneity in the outbred human population, it has been difficult to determine the genetic factors that influence the expressed T cell receptor (TcR) repertoire in autoimmune diseases. To overcome this problem, we have developed a combination of anchored polymerase chain reaction (APCR) and enzyme-linked immunosorbent assay (ELISA) that can accurately assess TcR V gene frequencies in numerous clinical samples. The results are independent of amplification efficiency, and V gene usage can be readily analyzed with an ELISA plate reader and associated software. Using this method, the TcR V beta gene repertoires in peripheral lymphocytes from nine sets of identical twins, normal, concordant or discordant for rheumatoid arthritis (RA), were studied. The TcR V beta results were compared with TcR V gamma frequencies in the same specimens as determined by APCR-ELISA and cDNA sequence analysis. The results showed a marked similarity in the TcR V beta gene repertoires between identical twins, compared to unrelated subjects (p < 0.05) whether or not they were concordant or discordant for RA. In contrast, the TcR V gamma gene repertoires in the monozygotic twins differed as much as in controls. The data imply that (a) the human TcR V beta gene repertoire in peripheral blood is genetically controlled, whereas (b) the TcR V gamma gene repertoire is primarily influenced by environmental stimuli, and (c) RA causes no consistent change in TcR V beta repertoire of peripheral blood. The APCR-ELISA method, in the context of large-scale family and population studies, should facilitate a more precise delineation of the genetic factors that regulate human TcR V beta expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344352     DOI: 10.1002/eji.1830230825

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  T cell receptor usage in autoimmune disease.

Authors:  P Moss; J Bell
Journal:  Springer Semin Immunopathol       Date:  1999

2.  The human immunoglobulin V(H) gene repertoire is genetically controlled and unaltered by chronic autoimmune stimulation.

Authors:  H Kohsaka; D A Carson; L Z Rassenti; W E Ollier; P P Chen; T J Kipps; N Miyasaka
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

Review 3.  T cell receptor analysis in rheumatoid arthritis: what have we learnt?

Authors:  S H Zwillich; D B Weiner; W V Williams
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

4.  Genetic control of T cell receptor BJ gene expression in peripheral lymphocytes of normal and rheumatoid arthritis monozygotic twins.

Authors:  T Nanki; H Kohsaka; N Mizushima; W E Ollier; D A Carson; N Miyasaka
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

Review 5.  T-cell antigen receptors in rheumatoid arthritis.

Authors:  L I Sakkas; P F Chen; C D Platsoucas
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

6.  Crossreactive public TCR sequences undergo positive selection in the human thymic repertoire.

Authors:  Mohsen Khosravi-Maharlooei; Aleksandar Obradovic; Aditya Misra; Keshav Motwani; Markus Holzl; Howard R Seay; Susan DeWolf; Grace Nauman; Nichole Danzl; Haowei Li; Siu-Hong Ho; Robert Winchester; Yufeng Shen; Todd M Brusko; Megan Sykes
Journal:  J Clin Invest       Date:  2019-03-28       Impact factor: 19.456

Review 7.  Association of MHC and rheumatoid arthritis. Association of RA with HLA-DR4: the role of repertoire selection.

Authors:  J Roudier
Journal:  Arthritis Res       Date:  2000-04-12

Review 8.  High Throughput Human T Cell Receptor Sequencing: A New Window Into Repertoire Establishment and Alloreactivity.

Authors:  Jianing Fu; Mohsen Khosravi-Maharlooei; Megan Sykes
Journal:  Front Immunol       Date:  2021-11-05       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.